Engineering Antibodies for the Treatment of Infectious Diseases
Author:
Publisher
Springer International Publishing
Link
http://link.springer.com/content/pdf/10.1007/978-3-319-72077-7_10
Reference76 articles.
1. Abboud N, Chow S-K, Saylor C, Janda A, Ravetch JV, Scharff MD, Casadevall A (2010) A requirement for FcγR in antibody-mediated bacterial toxin neutralization. J Exp Med 207:2395–2405. https://doi.org/10.1084/jem.20100995
2. Babcock GJ, Iyer S, Smith HL, Wang Y, Rowley K, Ambrosino DM, Zamore PD, Pierce BG et al (2014) High-throughput sequencing analysis of post-liver transplantation HCV E2 glycoprotein evolution in the presence and absence of neutralizing monoclonal antibody. PLoS One 9:e100325. https://doi.org/10.1371/journal.pone.0100325
3. Baca M, Presta LG, O’Connor SJ, Wells JA (1997) Antibody humanization using monovalent phage display. J Biol Chem 272:10678–10684
4. Bartelds GM, Wolbink GJ, Stapel S, Aarden L, Lems WF, Dijkmans BAC, Nurmohamed MT (2006) High levels of human anti-human antibodies to adalimumab in a patient not responding to adalimumab treatment. Ann Rheum Dis 65:1249–1250. https://doi.org/10.1136/ard.2005.049858
5. Beigel JH, Nordstrom JL, Pillemer SR, Roncal C, Goldwater DR, Li H, Holland PC, Johnson S et al (2010) Safety and pharmacokinetics of single intravenous dose of MGAWN1, a novel monoclonal antibody to West Nile virus. Antimicrob Agents Chemother 54:2431–2436. https://doi.org/10.1128/AAC.01178-09
Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Polyclonal Antibodies Derived from Transchromosomic Bovines Vaccinated with the Recombinant F1-V Vaccine Increase Bacterial Opsonization In Vitro and Protect Mice from Pneumonic Plague;Antibodies;2023-05-08
2. Cell Membrane-Coated Nanoparticles for Management of Infectious Diseases: A Review;Industrial & Engineering Chemistry Research;2022-08-29
3. Development of broadly neutralizing antibodies targeting the cytomegalovirus subdominant antigen gH;Communications Biology;2022-04-25
4. Human monoclonal antibodies for discovery, therapy, and vaccine acceleration;Current Opinion in Immunology;2019-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3